# Ixensor Co, Ltd.

- Location (FDA's records): Taipei City, TW
- FDA decisions: 3 (2017–2019): 3 510(k) clearances
- Names in FDA's records: Ixensor Co, Ltd. (2); Ixensor Company , Ltd. (1)
- Product codes: LCP (2), NBW (1)
- 510(k) review time since 2016: median 269 days, against 269 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 1 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Roche Diagnostics Corp.: 1 (https://510kreport.com/company/roche-diagnostics)

## Recent decisions
- K192369: PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test Kit (Oct 29, 2019)
- K181915: PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test Kit (Apr 12, 2019)
- K163087: PixoTest Blood Glucose Monitoring System (Nov 2, 2017)

Source page: https://510kreport.com/company/ixensor